Dr. Lal PathLabs Ltd
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹2182
- Today's High:
- ₹2238.45
- Open Price:
- ₹2201.05
- 52W Low:
- ₹1762.7
- 52W High:
- ₹2752.1499
- Prev. Close:
- ₹2219.3501
- Volume:
- 2702
Company Statistics
- Market Cap.:
- ₹198.81 billion
- Book Value:
- 201.014
- Revenue TTM:
- ₹20.17 billion
- Operating Margin TTM:
- 16.84%
- Gross Profit TTM:
- ₹7.58 billion
- Profit Margin:
- 11.85%
- Return on Assets TTM:
- 8.96%
- Return on Equity TTM:
- 14.87%
Company Profile
Dr. Lal PathLabs Ltd had its IPO on under the ticker symbol LALPATHLAB.
The company operates in the Healthcare sector and Diagnostics & Research industry. Dr. Lal PathLabs Ltd has a staff strength of 0 employees.
Stock update
Shares of Dr. Lal PathLabs Ltd opened at ₹2201.05 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹2182 - ₹2238.45, and closed at ₹2205.4.
This is a -0.63% slip from the previous day's closing price.
A total volume of 2,702 shares were traded at the close of the day’s session.
In the last one week, shares of Dr. Lal PathLabs Ltd have increased by +1.62%.
Dr. Lal PathLabs Ltd's Key Ratios
Dr. Lal PathLabs Ltd has a market cap of ₹198.81 billion, indicating a price to book ratio of 12.7034 and a price to sales ratio of 9.7764.
In the last 12-months Dr. Lal PathLabs Ltd’s revenue was ₹20.17 billion with a gross profit of ₹7.58 billion and an EBITDA of ₹4.90 billion. The EBITDA ratio measures Dr. Lal PathLabs Ltd's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Dr. Lal PathLabs Ltd’s operating margin was 16.84% while its return on assets stood at 8.96% with a return of equity of 14.87%.
In Q1, Dr. Lal PathLabs Ltd’s quarterly earnings growth was a negative -7.6% while revenue growth was a positive 1.1%.
Dr. Lal PathLabs Ltd’s PE and PEG Ratio
- Forward PE
- 62.1118
- Trailing PE
- 83.2066
- PEG
Its diluted EPS in the last 12-months stands at ₹28.8 per share while it has a forward price to earnings multiple of 62.1118 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Dr. Lal PathLabs Ltd’s profitability.
Dr. Lal PathLabs Ltd stock is trading at a EV to sales ratio of 9.6352 and a EV to EBITDA ratio of 36.5167. Its price to sales ratio in the trailing 12-months stood at 9.7764.
Dr. Lal PathLabs Ltd stock pays annual dividends of ₹12 per share, indicating a yield of 0.52% and a payout ratio of 20.88%.
Balance sheet and cash flow metrics
- Total Assets
- ₹23.86 billion
- Total Liabilities
- ₹4.70 billion
- Operating Cash Flow
- ₹-2873000000.00
- Capital Expenditure
- ₹446 million
- Dividend Payout Ratio
- 20.88%
Dr. Lal PathLabs Ltd ended 2024 with ₹23.86 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹23.86 billion while shareholder equity stood at ₹16.66 billion.
Dr. Lal PathLabs Ltd ended 2024 with ₹0 in deferred long-term liabilities, ₹4.70 billion in other current liabilities, 834000000.00 in common stock, ₹15.83 billion in retained earnings and ₹5.48 billion in goodwill. Its cash balance stood at ₹2.64 billion and cash and short-term investments were ₹8.51 billion. The company’s total short-term debt was ₹1,533,000,000 while long-term debt stood at ₹833.00 million.
Dr. Lal PathLabs Ltd’s total current assets stands at ₹9.73 billion while long-term investments were ₹0 and short-term investments were ₹1.86 billion. Its net receivables were ₹708.00 million compared to accounts payable of ₹1.56 billion and inventory worth ₹338.00 million.
In 2024, Dr. Lal PathLabs Ltd's operating cash flow was ₹-2873000000.00 while its capital expenditure stood at ₹446 million.
Comparatively, Dr. Lal PathLabs Ltd paid ₹0.21 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹2205.4
- 52-Week High
- ₹2752.1499
- 52-Week Low
- ₹1762.7
- Analyst Target Price
- ₹
Dr. Lal PathLabs Ltd stock is currently trading at ₹2205.4 per share. It touched a 52-week high of ₹2752.1499 and a 52-week low of ₹2752.1499. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹2291.64 and 200-day moving average was ₹2115.62 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 5749.7% of the company’s stock are held by insiders while 2218.8% are held by institutions.
Frequently Asked Questions About Dr. Lal PathLabs Ltd
Similar Industry Stocks (Diagnostics & Research)
Most Active
Top Gainers
Top Losers
About
Dr. Lal PathLabs Limited provides diagnostic and related healthcare tests and services in India and internationally. It operates laboratories for carrying the pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. The company also offers lab staff training; technical; and lab management services. As of March 31, 2022, the company had 277 clinical laboratories, including National Reference Lab at Delhi and Regional Reference Lab at Kolkata; and 4,731 patient service centers and 10,599 pick-up points. Dr. Lal PathLabs Limited was founded in 1949 and is based in Gurugram, India.